
Didcot, UK, 15 February 2006: The Company has made an application for the admission to trading on AIM of 461,979 ordinary shares (representing 0.94 per cent of the Company’s current issued share capital). These shares are being issued following the exercise of options by Mr John Kerslake and Mr Antony Canning.
The shares to be admitted to AIM rank pari passu in all respects with the existing ordinary shares. It is expected that dealings in these ordinary shares will commence at 8 am on 21 February 2006.
Lombard Medical Technologies PLC
Rhod Jones
Company Secretary
Tel: + 44 (0) 1235 750 865
For further information please see www.lombardmedical.com.